These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 16607958)

  • 1. [Preparation of recombinant HIV-TATm-survivin (T34A) protein and its pro-apoptosis activity to cancer cells in vitro].
    Zheng WY; Ma XY; Wei DZ; Wang JZ; Liu QH; Ma YS; Yang SL
    Sheng Wu Gong Cheng Xue Bao; 2006 Mar; 22(2):285-92. PubMed ID: 16607958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-level expression, purification and pro-apoptosis activity of HIV-TAT-survivin (T34A) mutant to cancer cells in vitro.
    Ma X; Zheng W; Wei D; Ma Y; Wang T; Wang J; Liu Q; Yang S
    J Biotechnol; 2006 May; 123(3):367-78. PubMed ID: 16406157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction, expression, and purification of HIV-TAT-survivin (T34A) mutant: a pro-apoptosis protein in Escherichia coli.
    Ma X; Zheng W; Wei D; Ma Y; Wang T; Wang J; Liu Q; Yang S
    Protein Expr Purif; 2006 May; 47(1):36-44. PubMed ID: 16260148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect on apoptosis and cell cycle of recombinant double negative dominant mutation Survivin (T34/117A) in breast cancer cell B-Cap-37.
    Wang L; Kang Y; Zheng W; Li L; Shi L; Ma X
    Biomed Pharmacother; 2014 Apr; 68(3):277-84. PubMed ID: 24513056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cloning, expression, and purification of the recombinant pro-apoptotic dominant-negative survivin T34A-C84A protein in Escherichia coli.
    Tsai SL; Chang YC; Sarvagalla S; Wang S; Coumar MS; Cheung CHA
    Protein Expr Purif; 2019 Aug; 160():73-83. PubMed ID: 31004782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient inhibition of ovarian cancer by degradable nanoparticle-delivered survivin T34A gene.
    Luo L; Du T; Zhang J; Zhao W; Cheng H; Yang Y; Wu Y; Wang C; Men K; Gou M
    Int J Nanomedicine; 2016; 11():501-12. PubMed ID: 26893558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and purification of TAT-NDRG2 recombinant protein and evaluation of its anti-proliferative effect on LNCaP cell line.
    Farokhinejad F; Behbahani AB; Rafiei Dehbidi GR; Takhshid MA
    Protein Expr Purif; 2017 Oct; 138():25-33. PubMed ID: 28711733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pro-apoptosis and anti-proliferation effects of a recombinant dominant-negative survivin-T34A in human cancer cells.
    Shen C; Liu W; Buck AK; Reske SN
    Anticancer Res; 2009 Apr; 29(4):1423-8. PubMed ID: 19414397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anti-prostate cancer activity of Survivin-T34A mutant in vitro and in vivo].
    Pan L; Peng XC; Yuan QZ; Leng F; Yu DD; Shan Y; Li ZY; Wang CT
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 May; 41(3):390-3. PubMed ID: 20629305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic protein TmSm(T34A) enhances sensitivity of chemotherapy to breast cancer cell lines as a synergistic drug to doxorubicin.
    Xu Y; Zheng W; Wang T; Wang P; Zhu L; Ma X
    Biomed Pharmacother; 2012 Jul; 66(5):368-72. PubMed ID: 22560635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prokaryotic expression, purification and antigenicity identification of recombinant human survivin protein].
    Yin X; Wang W; Tian R; Xu Y; Yan J; Zhang W; Gao J; Yu J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Aug; 29(8):877-81. PubMed ID: 23948420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of melanoma cell apoptosis and inhibition of tumor growth using a cell-permeable Survivin antagonist.
    Yan H; Thomas J; Liu T; Raj D; London N; Tandeski T; Leachman SA; Lee RM; Grossman D
    Oncogene; 2006 Nov; 25(52):6968-74. PubMed ID: 16702945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A recombinant protein TmSm(T34A) can inhibit proliferation and proapoptosis to breast cancer stem cells(BCSCs) by down-regulating the expression of Cyclin D1.
    Ma X; Zhang Y; Kang Y; Li L; Zheng W
    Biomed Pharmacother; 2016 Dec; 84():373-381. PubMed ID: 27668537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant human Tat-Hsp70-2: A tool for neuroprotection.
    Cappelletti P; Binda E; Tunesi M; Albani D; Giordano C; Molla G; Pollegioni L
    Protein Expr Purif; 2017 Oct; 138():18-24. PubMed ID: 27405095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-TAT-fused FHIT protein functions as a potential pro-apoptotic molecule in hepatocellular carcinoma cells.
    Yu GR; Qin WW; Li JP; Hua W; Meng YL; Chen R; Yan B; Wang L; Zhang X; Jia LT; Zhao J; Zhang R; Yang AG
    Biosci Rep; 2012 Jun; 32(3):271-9. PubMed ID: 21679157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The fusion construction of HIV-1 Tat gene and efficient expression in E.coli].
    Lin JP; Wang H; Wang L; Wei HF; Hu XP; Wang LY; Yu YL
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Jan; 21(1):33-6. PubMed ID: 15629079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of Survivin-T34A mutant on breast cancer cell in vitro and in vivo].
    Deng X; Song H; Ren M
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2014 Jun; 31(3):648-51. PubMed ID: 25219251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient inhibition of murine breast cancer growth and metastasis by gene transferred mouse survivin Thr34-->Ala mutant.
    Peng XC; Yang L; Yang LP; Mao YQ; Yang HS; Liu JY; Zhang DM; Chen LJ; Wei YQ
    J Exp Clin Cancer Res; 2008 Sep; 27(1):46. PubMed ID: 18816410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cloning, expression and identification of human survivin in E. coli].
    Bie J; Sun MS; Sun QM; Zheng JP; Sun WJ
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Aug; 24(8):913-6. PubMed ID: 15321760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel method for promoting heterologous protein expression in Escherichia coli by fusion with the HIV-1 TAT core domain.
    Wu Y; Ren C; Gao Y; Hou B; Chen T; Zhang C
    Amino Acids; 2010 Aug; 39(3):811-20. PubMed ID: 20213440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.